Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

413.84
Delayed Data
As of Feb 27
 -6.03 / -1.44%
Today’s Change
269.50
Today|||52-Week Range
437.64
+0.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues445.8M1.4B2.1B2.8B
 
 
 
 
 
Cost of Goods Sold4.2M84.5M155.4M205.0M
 
 
 
 
 
Depreciation And Amortization31.1M36.9M41.2M52.7M
 
 
 
 
 
 
Operating ExpensesGross Income410.5M1.3B1.9B2.6B
 
 
 
 
 
General Expenses615.7M796.6M1.1B1.7B
 
 
 
 
 
Research And Development498.4M588.6M818.7M1.2B
 
 
 
 
 
Total Operating Expenses651.0M918.0M1.3B2.0B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-205.2M460.5M760.5M838.4M
 
 
 
 
 
Extraordinary Credit0.000.000.001.2M
 
 
Extraordinary Charge0.000.00-2.9M-33.5M
 
 
 
Interest Expense On Debt21.3M45.3M46.4M43.6M
 
 
 
 
 
Other Expenses0.00-2.8M-499.0K1.2M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-222.9M414.4M713.4M775.7M
 
 
 
 
 
Income Taxes-1.1M-335.8M-289.0M-427.7M
 
 
 
 
 
Net Income-221.8M750.3M424.4M348.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS90.6M94.7M97.9M100.6M
 
 
 
 
 
Shares To Calculate EPS Diluted90.6M115.4M111.3M113.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.45$6.75$3.81$3.07
 
 
 
 
 
EPS Diluted-$2.45$6.75$3.81$3.07
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account